I see that Market Screener shows average forecast of 4 brokers FY23 at EBIT $82m, and NPAT $55.9m for a PE of just 6.6.
(with Capex v similar to DA and $67m free cashflow. All 4 rate it a BUY with av TP $1.35).
Equally important, their strong balance sheet, diversification, market position and predominant exposure to well-funded producers (not early stage explorers) limits downside risk.